Mage Biotechnologies Revenue
Biotechnology Research • 
London, England, United Kingdom • 11-20 Employees
Mage Biotechnologies revenue & valuation
| Annual revenue | $1,368,880 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,400,000 |
| Total funding | No funding |
Key Contacts at Mage Biotechnologies
Sahar Ghannam
Co-Founder
Eda Pelin Aksu
Marketing Director
Diane Duncan
Co-Founder
Company overview
| Headquarters | Kennington Lane, 239-241, London, England SE11 5QU, GB |
| Website | |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Mage Biotechnologies Email Formats
Mage Biotechnologies uses 4 email formats. The most common is {first initial} (e.g., j@magegroup.co.uk), used 30% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@magegroup.co.uk | 30% |
{first name} | john@magegroup.co.uk | 30% |
{second initial} | o@magegroup.co.uk | 20% |
{first name}.{last name} | john.doe@magegroup.co.uk | 20% |
About Mage Biotechnologies
Mage Biotechnologies is a holding company active in the fields of longevity and regenerative medicine. Our core areas of expertise are in stem-cell-based and exosome-based technologies. We undertake our business activities through several subsidiaries: Lipocube https://www.linkedin.com/company/lipocube-biotechnology/ https://lipocube.com/ Lipocube specializes in the development of advanced medical devices that enable the extraction and processing of autologous adipose-based stem cells. Recure https://www.linkedin.com/company/recure-cosmetics/ https://morphiya.com/ Recure develops, produces and markets cosmetics, supplements, and injectables featuring our proprietary Hybrid Exosomes (Hybrosomes™) technology that promote tissue regeneration and rejuvenation. London Regenerative Institute https://www.linkedin.com/company/london-regenerative-institute/ https://london-regenerative.com/ LRI provides diagnostics, treatments, and clinical services that help individuals live healthier and longer lives. Coming Soon: Exocube: Exocube will introduce medical devices for the extraction and processing of autologous exosomes, bringing yet another dimension to regenerative medicine. At Mage Biotechnologies, we are dedicated to pushing the boundaries of science and technology to deliver transformative solutions that foster longevity and well-being. Follow us to keep informed on our journey of innovation, and stay tuned for what's on the horizon.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Mage Biotechnologies has 8 employees across 7 departments.
Departments
Number of employees
Funding Data
Mage Biotechnologies has never raised funding before.
Mage Biotechnologies Tech Stack
Discover the technologies and tools that power Mage Biotechnologies's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
WordPress plugins
Miscellaneous
Programming languages
Blogs
JavaScript libraries
Databases
Page builders
Miscellaneous
Performance
Font scripts
Spain
Sweden
Frequently asked questions
4.8
40,000 users
